Peter J. Gundermann
Analyst · CJS Securities
Thanks, Craig and good morning everybody. Thanks for tuning in. We're going to first talk about Q4, which was a little bit weaker than we wanted, but generally consistent with both the preceding quarter and our comparator quarter. We'll then do a post-mortem on 2016, now that it's over, which in general was fine with us. We're ready to move on to 2017, which will be our third topic. And give some initial colors to what we expect to unfold over the course of the year. So starting with the quarter, the fourth quarter revenue was $154 million, slightly below our comparator quarter of the fourth quarter of 2015, and pretty much even sequentially with the third quarter of 2016. Aero sales were $128 million, up from Q3 but still one of our weaker quarters in 2016. Test sales were $26 million, down from $30 million in the third quarter but better than the first couple quarters of the year when we were in the $21 million to $22 million range. Bottom line results were also a little bit lighter than we would have liked, net income was $9.9 million, 6.4% of sales, diluted earnings per share of $0.33, down from $0.46 in 2015. If you look at the tax line that largely explains the differences between the fourth quarter 2016 and the fourth quarter of 2015 with a very light tax rate in 2015 and a much more normal tax rate in 2016. Engineering and development expense for the quarter was $22.7 million, 14.7% of sales, down slightly from last year and consistent with recent quarters. Bookings were little light also at $137 million, about the same as Q3. Aerospace was $113.8 million and Test was $23 million, book-to-bill of 0.89. Backlog at the end of the quarter and the end of the year was $258 million. Moving from the quarter to the year, revenue for the year ended up being at $633 million, down 8.5% from $692 million in 2015. 2016 as a year marks the first time since 2003 where we recorded a sequential decline in sales from one year to the next. The drop of $59 million can largely be explained by two events or situations. One is a reduction in our Semiconductor Test product line, which was $54 million, again $54 million on a total decline of $59 million. And our Avionics product line declined $23 million. So those two together the Semi-test and the Avionics product line explains the decline in revenues of $77 million. The rest of the business cumulatively fought some of that back, so that instead of a $77 million decline, we ended up at $59 million. Net income, jumping to the bottom line, for the year was $48.4 million, down from $67 million in 2015. Our net income margin was 7.6% of sales, a $1.61 per diluted share versus $2.22 in 2015. The margin decline was generally driven by this 1% drop in aerospace operating profit but a substantial drop in Test that you might expect looking at the drop in revenue. 2016 bookings ended up at $617 million, roughly equal to sales with the book-to-bill of 0.97. This despite a weak bookings quarter in Q3 and Q4. You might remember Q2 was one of our best booking quarters ever, and Q1 was pretty strong also. So if you take it as a moving four quarter average, roughly worked out to be in the same neighborhood as sales. And again backlog going into 2017 was $258 million. Looking at our segments starting with aerospace, year-to-date revenues were $534 million, about 84% of our consolidated total and down marginally 2.9% compared to $550 million in 2015. That decline of $15.7 million was again more than explained by Avionics which was down $23 million for the year. Operating profit turned out to be $78 million, 14.6% of sales down from $85 million or 15.5% of sales in 2015. Sales by market, looking at the table in the back of the press release, commercial transports were $435 million, of our sales 69% of total, down 4.4%, again mostly driven by Avionics in that case. Military turned out to be $55 million, 8.6% of our total sales and up 26% largely driven by some military missile products that we have. Business Jet sales turned out to be $25 million, only 4% of sales and down 22% from 2015, largely driven by in-flight entertainment systems that we make for VVIP airplanes. So a lot of movement in our Aerospace business. If you cut it a different way and look at it by product lines, our electrical power and motion product line which includes our In-Seat power franchise was $289 million, 45% of our total revenue, and up 3% for the year. Lighting and safety was a $157 million, about flat with 2015 and 25% of our total sales. Avionics, this is the one again that was the big mover for aerospace, $33 million in sales in 2016, down 42% over 2015, and making up 5.2% of our total. And finally our system certification product lines $16.5 million, down 22%, only 2.6% of our total sales. Moving to Test, revenues in the fourth quarter were $26 million, up 25% over the comparative period of the fourth quarter of 2015. Operating profit of $2 million, 7.6% of sales. Year-to-date, our Test segment reported revenues just shy of $100 million. That’s down 30% from $142 million in 2015, a decline in semiconductor Test sales was somewhat offset by an increase in our traditional Aerospace and Defense test sales. Bookings year-to-date where $76 million, book-to-bill with 0.77. The news here is, is that obviously in 2016 we did not record a substantial semiconductor test orders, but to the extent we had semiconductor sales that would erode our backlog. Our backlog at the end of the year for Test was $38.9 million. Our balance sheet we consider very healthy, cash of $18 million at the end of the year, a total debt of a $148 million for net-debt of a $130 million. Year-to-date on our share repurchase plan by the end of the year we bought 523,000 shares at $17.6 million. The total authorization was for $50 million. So we have $33 million remaining. And finally looking forward, talking about 2017 we are issuing initial guidance for 2017 of $640 million to $720 million. We expect our Aerospace segment to be in the $560 million to $600 million range. The midpoint there has us growing at 8.6% over 2016. Our Test business we're coming out with initial revenue guidance of $80 million to $120 million. So that's a pretty wide range and it reflects a number of open issues that we have in the market that collectively could throw us off the midpoint pretty strongly one way or the other. We're putting a plus or minus 20% on that midpoint range. So we could very easily -- and our goal is to be towards the high end of that range. $120 million would be an increase of 20% over 2016. But it's possible if everything were to go the wrong way we end up at other end and that's a negative 20%, down around $80 million. We will report on those -- on those orders as they develop, as quickly as we can but today, we think it's prudent to take a pretty wide range. When you look at the year, we're expecting the year to grow in momentum, based on the scheduling of programs as we see it. We expect the first quarter to look quite a bit like the third quarter and fourth quarter of 2016 and we expect the second quarter and third quarter to represent a step up and the fourth quarter represent another step up to make our budgeted numbers. So it'll be a year of growing momentum, if everything works to plan. I think that is my -- that concludes my prepared remarks. Manny if you want to open up the lines for question we'll take them now.